Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Diane Corey

Showing results (11-20 of 18) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 18 results.
Atherosclerosis|September 15, 2005
Genome scan of systemic biomarkers of vascular inflammation in the Framingham Heart Study: evidence for susceptibility loci on 1qJosée Dupuis, Martin G Larson, Ramachandran S Vasan, et al.
Circulation|June 7, 2006
Single-gene mutations and increased left ventricular wall thickness in the community: the Framingham Heart StudyHiroyuki Morita, Martin G Larson, Scott C Barr, et al.
American Heart Journal|July 24, 2007
Clinical and echocardiographic correlates of plasma procollagen type III amino-terminal peptide levels in the communityThomas J Wang, Martin G Larson, Emelia J Benjamin, et al.
The American Journal of Cardiology|May 29, 2007
Association of multiple inflammatory markers with carotid intimal medial thickness and stenosis (from the Framingham Heart Study)Avni H Thakore, Chao-Yu Guo, Martin G Larson, et al.
Arteriosclerosis, Thrombosis, and Vascular Biology|May 8, 2010
Biomarkers of the osteoprotegerin pathway: clinical correlates, subclinical disease, incident cardiovascular disease, and mortalityWolfgang Lieb, Philimon Gona, Martin G Larson, et al.
American Journal of Hypertension|May 11, 2005
Clinical and genetic correlates of serum aldosterone in the community: the Framingham Heart StudySekar Kathiresan, Martin G Larson, Emelia J Benjamin, et al.
American Journal of Epidemiology|March 21, 2007
The Third Generation Cohort of the National Heart, Lung, and Blood Institute's Framingham Heart Study: design, recruitment, and initial examinationGreta Lee Splansky, Diane Corey, Qiong Yang, et al.
CPT: Pharmacometrics & Systems Pharmacology|November 27, 2024
A computational tool to optimize clinical trial parameter selection in Duchenne muscular dystrophy: A practical guide and case studiesJordan Wilk, Varun Aggarwal, Mike Pauley, et al.
Pageof 2

Showing results (11-20 of 18) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 18 results.
Atherosclerosis|September 15, 2005
Genome scan of systemic biomarkers of vascular inflammation in the Framingham Heart Study: evidence for susceptibility loci on 1qJosée Dupuis, Martin G Larson, Ramachandran S Vasan, et al.
Circulation|June 7, 2006
Single-gene mutations and increased left ventricular wall thickness in the community: the Framingham Heart StudyHiroyuki Morita, Martin G Larson, Scott C Barr, et al.
American Heart Journal|July 24, 2007
Clinical and echocardiographic correlates of plasma procollagen type III amino-terminal peptide levels in the communityThomas J Wang, Martin G Larson, Emelia J Benjamin, et al.
The American Journal of Cardiology|May 29, 2007
Association of multiple inflammatory markers with carotid intimal medial thickness and stenosis (from the Framingham Heart Study)Avni H Thakore, Chao-Yu Guo, Martin G Larson, et al.
Arteriosclerosis, Thrombosis, and Vascular Biology|May 8, 2010
Biomarkers of the osteoprotegerin pathway: clinical correlates, subclinical disease, incident cardiovascular disease, and mortalityWolfgang Lieb, Philimon Gona, Martin G Larson, et al.
American Journal of Hypertension|May 11, 2005
Clinical and genetic correlates of serum aldosterone in the community: the Framingham Heart StudySekar Kathiresan, Martin G Larson, Emelia J Benjamin, et al.
American Journal of Epidemiology|March 21, 2007
The Third Generation Cohort of the National Heart, Lung, and Blood Institute's Framingham Heart Study: design, recruitment, and initial examinationGreta Lee Splansky, Diane Corey, Qiong Yang, et al.
CPT: Pharmacometrics & Systems Pharmacology|November 27, 2024
A computational tool to optimize clinical trial parameter selection in Duchenne muscular dystrophy: A practical guide and case studiesJordan Wilk, Varun Aggarwal, Mike Pauley, et al.
Pageof 2